Medical News

RSS

Tests of cognitive function are the best way so far to predict whether healthy elderly people will develop Alzheimer's

Although Alzheimer's disease begins long before symptoms appear, early diagnosis of Alzheimer's has so far been elusive. And given that there is no cure for the disease, benefits of early detection remain questionable.

26 Sep 2005

Potential oral drug for rheumatoid arthritis

A potential oral drug for rheumatoid arthritis (RA) may encourage women to treat their condition earlier rather than later because it is less arduous than currently available treatments. Early treatment is important because RA most often develops between the ages of 35 and 50 and is two- to three times more prevalent in women.

26 Sep 2005

New method of radiation treatment may improve the local control of breast cancer

A new method of radiation treatment may improve the local control of breast cancer significantly which, is very important to cancer sufferers because it can preserve the breast and may also reduce the spread of the disease.

26 Sep 2005

Microchip system aims to reduce the number of animals used in the development of new drugs

Reducing the number of animals used in the development of new drugs is a priority for the pharmaceutical industry

26 Sep 2005

A new, less toxic way to treat malignant melanoma

A new, less toxic way to treat malignant melanoma (skin cancer) is being developed by medicinal chemists at Reading University. They have produced a range of prodrugs: compounds that offer the potential to be converted to toxic molecules only within the vicinity of tumours. These prodrugs aim to reduce the toxicity of treatment.

26 Sep 2005

Pharmacists can play a vital role in bridging the care gap for patients with cystic fibrosis

Patients with cystic fibrosis typically take large numbers of medicines and are managed by healthcare professionals in both primary and secondary care. Most of patients' regular medication is prescribed by general practitioners, whereas complex and new treatments are initiated and provided through hospital outpatient clinics.

26 Sep 2005

Extreme gene pin-pointed

One teenager likes to snowboard off a cliff. Another prefers to read a book and wouldn't think of trading places. Why these differences exist is a mystery, but for the first time researchers have identified a possible genetic explanation behind risk-seeking behavior.

26 Sep 2005

Mutations in receptor tyrosine kinases provide potential for highly-targeted cancer therapies

Scientists from J. Craig Venter Institute, Ludwig Institute for Cancer Research, and The Johns Hopkins University School of Medicine identified three novel mutations in two receptor tyrosine kinases in glioblastoma tumors using high throughput sequencing.

26 Sep 2005

Parents' Views on School Wellness Practices

A new national survey of parents of school-aged children found a significant gap between what parents believe is happening and what is actually happening in terms of nutrition and physical activity in America's schools.

26 Sep 2005

Clinical trial participants may not be as unrepresentative of general clinical populations as often reported

It is often suggested that the results of clinical trials are affected by the fact that the patients who volunteer for a trial are more likely to take their medication effectively than those in standard care. This supposition is, however, strongly refuted in the results of a new study revealed at the British Pharmaceutical Conference in Manchester.

26 Sep 2005

Pharmacists can drastically reduce patients worries about using steroids

For those people who suffer from eczema, the use of topical corticosteroids is high up on their list of concerns: How should they be used? And are they safe?

26 Sep 2005

New study into the health-related quality of life for human immunodeficiency virus (HIV) patients

Pharmacists in Wales have conducted a new study into the health-related quality of life for human immunodeficiency virus (HIV) patients. The surprising results were revealed at the British Pharmaceutical Conference in Manchester.

26 Sep 2005

Vaccine candidate? Researchers synthesize oligosaccharide from anthrax pathogen

For weeks a white powder caused fear and shock for the American population: a few days after the attacks on September 11th, 2001, four innocent people became the victims of letters that contained the powder - spores of the anthrax pathogen. German researchers have now synthesized a molecule characteristic of anthrax in the laboratory which may be the basis for a new anthrax vaccine.

26 Sep 2005

State-of-the-art treatment program increases survival from the aggressive uterine papillary serous carcinoma

"Our study defines a standard of care for this aggressive and growing form of uterine cancer," said Schwartz, who is also assistant chief of obstetrics and gynecology at Yale-New Haven Hospital. The procedure more accurately determines the complete stage and appropriate treatment and reduces the recurrence of the cancer.

26 Sep 2005

Simple, fast and effective method of detecting a large number of patients at high risk for hereditary breast/ovarian cancer

One in five women diagnosed with breast or ovarian cancer who seek mammography have a family history of cancer that suggests they may harbor known cancer-causing gene mutations.

26 Sep 2005

Aquaporin-4 is the first specific molecule to be defined as a target for the autoimmune response in any form of MS

Researchers have identified a molecular suspect in a disorder similar to multiple sclerosis (MS) that attacks the optic nerve and spinal cord, according to a report presented at the 130th annual meeting of the American Neurological Association in San Diego. The protein, called aquaporin-4, is a channel protein that allows water to move in and out of cells.

26 Sep 2005

Medical News

Tests of cognitive function are the best way so far to predict whether healthy elderly people will develop Alzheimer's

Potential oral drug for rheumatoid arthritis

New method of radiation treatment may improve the local control of breast cancer

Microchip system aims to reduce the number of animals used in the development of new drugs

A new, less toxic way to treat malignant melanoma

Pharmacists can play a vital role in bridging the care gap for patients with cystic fibrosis

Extreme gene pin-pointed

Mutations in receptor tyrosine kinases provide potential for highly-targeted cancer therapies

Parents' Views on School Wellness Practices

Clinical trial participants may not be as unrepresentative of general clinical populations as often reported

Pharmacists can drastically reduce patients worries about using steroids

New study into the health-related quality of life for human immunodeficiency virus (HIV) patients

Vaccine candidate? Researchers synthesize oligosaccharide from anthrax pathogen

State-of-the-art treatment program increases survival from the aggressive uterine papillary serous carcinoma

Simple, fast and effective method of detecting a large number of patients at high risk for hereditary breast/ovarian cancer

Aquaporin-4 is the first specific molecule to be defined as a target for the autoimmune response in any form of MS

Surprising immune system cells discovery

Increasingly virulent Staph infections

Researchers have found a way to keep students awake during class

Abused children have a tendency to focus and respond to even subtle signs of anger from others

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News